Downstaging and Pathological Complete Response of Locally Recurrent Sarcomatoid Renal Cell Carcinoma under Pembrolizumab and Lenvatinib: A Case Report and Review of Literature

The advent of immune checkpoint inhibition opened new perspectives for patients with recurrent or metastasized renal cell carcinoma. In case of recurrent disease, surgical resection remains the most promising therapeutic option. Surgical resection is associated with improved overall survival and dem...

Descripción completa

Detalles Bibliográficos
Autores principales: Ell, Jascha, Balz, Philipp, Manava, Panagiota, Hüttenbrink, Clemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616667/
https://www.ncbi.nlm.nih.gov/pubmed/37915993
http://dx.doi.org/10.1159/000534000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616667/
https://www.ncbi.nlm.nih.gov/pubmed/37915993
http://dx.doi.org/10.1159/000534000

Ejemplares similares